ViGenCell announced on Wednesday that it has recruited two executives to oversee business development and GMP operations to ...

Last year, Korea’s national health insurance system recorded a surplus of 499.6 billion won ($350.8 million) in its ...

Dong-A ST announced on Wednesday that Health Canada has granted marketing authorization for Imuldosa (ingredient: ustekinumab ...

Concerns were raised that the range of medications available for treating severe obesity among children and adolescents ...

Daiichi Sankyo Korea said Wednesday that its targeted therapy for acute myeloid leukemia (AML), Vanflyta (quizartinib), has ...

SAN FRANCISCO, Calif. – By Hong Sook / Korea Biomedical Review correspondent -- Samjin Pharmaceutical, long known for its ...

Boryung Consumer Healthcare announced on Wednesday that it held shareholders' and board of directors' meetings, appointing ...

The Korean treatment landscape for ovarian cancer is poised for a significant shift as the first antibody-drug conjugate (ADC ...

Noul, an AI-based blood and cancer diagnostics specialist, said Wednesday that it has signed a contract to supply its ...

The recent recognition of Korea’s Ministry of Food and Drug Safety (MFDS) as an official reference body in the medical products sector by the United Arab Emirates (UAE) was known to have been influenc ...

HLB just put a second cancer program onto the FDA’s review track, this time aiming for an accelerated approval in bile duct ...

Hanmi Pharmaceutical is accelerating its global expansion around efpeglenatide, Korea’s first independently developed ...